[
  {
    "ts": null,
    "headline": "Why Gilead Sciences Stock Slipped Today",
    "summary": "Gilead Sciences (NASDAQ: GILD) didn't have a bad first quarter, but investors didn't find it inspiring either.  For the period, Gilead's revenue clocked in at $6.67 billion, essentially flat over the same quarter of 2024.  This was offset by improvements in liver disease and human immunodeficiency virus (HIV) medications.",
    "url": "https://finnhub.io/api/news?id=9265d5de3d15c07afbdf2a8d288c87c322211244c599fd3f32e2911a95602f59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745613816,
      "headline": "Why Gilead Sciences Stock Slipped Today",
      "id": 134104615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences (NASDAQ: GILD) didn't have a bad first quarter, but investors didn't find it inspiring either.  For the period, Gilead's revenue clocked in at $6.67 billion, essentially flat over the same quarter of 2024.  This was offset by improvements in liver disease and human immunodeficiency virus (HIV) medications.",
      "url": "https://finnhub.io/api/news?id=9265d5de3d15c07afbdf2a8d288c87c322211244c599fd3f32e2911a95602f59"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Friday when compared to competitors",
    "summary": "Gilead Sciences Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=a88d3471d567b5ca44858e0a00f9eccfca59367d084ce1d3fcbd0723495aa5ab",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745598900,
      "headline": "Gilead Sciences Inc. stock underperforms Friday when compared to competitors",
      "id": 134129636,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a88d3471d567b5ca44858e0a00f9eccfca59367d084ce1d3fcbd0723495aa5ab"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Delivers Lackluster Q1 Revenue on Trodelvy Miss, Oppenheimer Says",
    "summary": "Gilead Sciences (GILD) posted an unexpected drop in Q1 revenue amid a surprising miss from cancer dr",
    "url": "https://finnhub.io/api/news?id=2fa9372a4c38da389b837d75e6cece8ba3ee22463bd798084b74b7440b72ab3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745594900,
      "headline": "Gilead Delivers Lackluster Q1 Revenue on Trodelvy Miss, Oppenheimer Says",
      "id": 134094801,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences (GILD) posted an unexpected drop in Q1 revenue amid a surprising miss from cancer dr",
      "url": "https://finnhub.io/api/news?id=2fa9372a4c38da389b837d75e6cece8ba3ee22463bd798084b74b7440b72ab3b"
    }
  },
  {
    "ts": null,
    "headline": "GILD Down on Q1 Earnings and Sales Miss, Oncology Sales Decline",
    "summary": "Gilead Sciences' Q1 earnings and sales miss estimates on lower oncology drug sales. The stock is trading down.",
    "url": "https://finnhub.io/api/news?id=914211b09e27f90686c760aeb8f4bd9c72af68b2227e5a4fae1e6017ea3ad216",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745592060,
      "headline": "GILD Down on Q1 Earnings and Sales Miss, Oncology Sales Decline",
      "id": 134094802,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences' Q1 earnings and sales miss estimates on lower oncology drug sales. The stock is trading down.",
      "url": "https://finnhub.io/api/news?id=914211b09e27f90686c760aeb8f4bd9c72af68b2227e5a4fae1e6017ea3ad216"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue",
    "summary": "Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined.",
    "url": "https://finnhub.io/api/news?id=01720f7962381bc1da3dd6e54b571aa0aed2fcbad850ca0967250ae122a528d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745591410,
      "headline": "Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue",
      "id": 134087844,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined.",
      "url": "https://finnhub.io/api/news?id=01720f7962381bc1da3dd6e54b571aa0aed2fcbad850ca0967250ae122a528d6"
    }
  },
  {
    "ts": null,
    "headline": "Q1 2025 Gilead Sciences Inc Earnings Call",
    "summary": "Q1 2025 Gilead Sciences Inc Earnings Call",
    "url": "https://finnhub.io/api/news?id=028c7e67bff283dbabb751eabfd06acfd744d73890850ab55ac87672081b4cad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745588457,
      "headline": "Q1 2025 Gilead Sciences Inc Earnings Call",
      "id": 134087846,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Q1 2025 Gilead Sciences Inc Earnings Call",
      "url": "https://finnhub.io/api/news?id=028c7e67bff283dbabb751eabfd06acfd744d73890850ab55ac87672081b4cad"
    }
  },
  {
    "ts": null,
    "headline": "Gilead leans on HIV drugs as oncology sales slow",
    "summary": "The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for Trodelvy and its cancer cell therapies.",
    "url": "https://finnhub.io/api/news?id=c290feeaba5e088bc6e43ff35551daca62d883e48f5abb446ee598cba6006733",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745583000,
      "headline": "Gilead leans on HIV drugs as oncology sales slow",
      "id": 134094803,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for Trodelvy and its cancer cell therapies.",
      "url": "https://finnhub.io/api/news?id=c290feeaba5e088bc6e43ff35551daca62d883e48f5abb446ee598cba6006733"
    }
  },
  {
    "ts": null,
    "headline": "3 High Growth Tech Stocks Leading The US Market",
    "summary": "Over the last 7 days, the United States market has risen by 4.1%, and over the past 12 months, it is up by 7.9%, with earnings forecasted to grow by 14% annually. In this environment of robust growth, identifying high-growth tech stocks that align with these positive trends can be key to capitalizing on potential opportunities in the market.",
    "url": "https://finnhub.io/api/news?id=7a21c8ee8d8e96d65c505166ff566b419a03a36f11a4f57db31d3c78c24d8761",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745581085,
      "headline": "3 High Growth Tech Stocks Leading The US Market",
      "id": 134087848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Over the last 7 days, the United States market has risen by 4.1%, and over the past 12 months, it is up by 7.9%, with earnings forecasted to grow by 14% annually. In this environment of robust growth, identifying high-growth tech stocks that align with these positive trends can be key to capitalizing on potential opportunities in the market.",
      "url": "https://finnhub.io/api/news?id=7a21c8ee8d8e96d65c505166ff566b419a03a36f11a4f57db31d3c78c24d8761"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Q1 Earnings Review: HIV Division Masks Underperformance",
    "summary": "Gilead Sciences Q1 Earnings Review: HIV Division Masks Underperformance",
    "url": "https://finnhub.io/api/news?id=20092610a4bdac3732325adbd6cf6cb674f1f173a99907d8f65f6fb20cd654a4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745577307,
      "headline": "Gilead Sciences Q1 Earnings Review: HIV Division Masks Underperformance",
      "id": 134083351,
      "image": "",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=20092610a4bdac3732325adbd6cf6cb674f1f173a99907d8f65f6fb20cd654a4"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Earnings Were Solid. Why the Stock Is Dropping.",
    "summary": "Gilead Sciences Earnings Were Solid. Why the Stock Is Dropping.",
    "url": "https://finnhub.io/api/news?id=35bf03725a842d01fcf1683fff0a280d68faeb0cbe22900ab9b9fa4daf3d85d7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745575380,
      "headline": "Gilead Sciences Earnings Were Solid. Why the Stock Is Dropping.",
      "id": 134147649,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Earnings Were Solid. Why the Stock Is Dropping.",
      "url": "https://finnhub.io/api/news?id=35bf03725a842d01fcf1683fff0a280d68faeb0cbe22900ab9b9fa4daf3d85d7"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones Futures Fall After Nasdaq Runs On; Google Rises On Earnings, Tesla Rival Booms",
    "summary": "Dow Jones Futures Fall After Nasdaq Runs On; Google Rises On Earnings, Tesla Rival Booms",
    "url": "https://finnhub.io/api/news?id=35993c75eae633d2d570e0240bd2a2824bfefedcdb9e6e3d6152cc319e17857a",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745566750,
      "headline": "Dow Jones Futures Fall After Nasdaq Runs On; Google Rises On Earnings, Tesla Rival Booms",
      "id": 134071211,
      "image": "",
      "related": "GILD",
      "source": "DowJones",
      "summary": "Dow Jones Futures Fall After Nasdaq Runs On; Google Rises On Earnings, Tesla Rival Booms",
      "url": "https://finnhub.io/api/news?id=35993c75eae633d2d570e0240bd2a2824bfefedcdb9e6e3d6152cc319e17857a"
    }
  },
  {
    "ts": null,
    "headline": "Alphabet shares jump on strong results, Intel tumbles on outlook and other early movers",
    "summary": "Alphabet shares jump on strong results, Intel tumbles on outlook and other early movers",
    "url": "https://finnhub.io/api/news?id=afa3a66205af42e4f39146b2519142085e5089713a3049aa14d2ac1cc8521598",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745560152,
      "headline": "Alphabet shares jump on strong results, Intel tumbles on outlook and other early movers",
      "id": 134071235,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Alphabet shares jump on strong results, Intel tumbles on outlook and other early movers",
      "url": "https://finnhub.io/api/news?id=afa3a66205af42e4f39146b2519142085e5089713a3049aa14d2ac1cc8521598"
    }
  }
]